Skip to main content
. 2012 Mar 7;120(6):897–903. doi: 10.1289/ehp.1104522

Table 5.

DEHP and DiNP metabolites currently detected by MS in human amniotic fluid.

Metabolite Studya Detected LOD (ng/mL) Median (ng/mL)
DEHP
MEHP 1 (+) 0.86 < LOD
2 + 0.90 22.10
3 + 0.15 1.60
5OH-MEHP 1
3 (+) 0.15 < LOD
4 0.10
5oxo-MEHP 1
3 (+) 0.15 < LOD
4 0.03
5cx-MEPP 3 + 0.15 0.53
4 + 0.05 0.27
2cx-MMHP 3 + 0.15 0.64
DiNP
Monoisononyl phthalate 1
7OH-MMeOP 3 0.15
4 0.01
7oxo-MMeOP 3 0.15
4 0.02
7cx-MMeHP 3 (–)b 0.15
4 + 0.02 0.07
Symbols: – not detected, (+) poorly detected (median below LOD), + detected, — not available. aStudies: 1, Silva et al. (2004), United States; 2, Huang et al. (2009), Taiwan; 3, Wittassek et al. (2009), Germany; 4, present study, Denmark. b7cx-MMeHP was detected in only 1 of 11 samples.
HHS Vulnerability Disclosure